Navigation Links
EastMed Inc. receives FDA clearance to market uresta(TM) in the U.S.
Date:11/25/2008

NORWELL, MA, Nov. 25 /PRNewswire/ - EastMed Inc., the medical manufacturing company that caters specifically to women's health and wellness, has received FDA clearance to market its flagship product, uresta(TM) Continence Care, in the U.S.

"We are delighted to get the official word from the FDA," said James Lodigiani, CEO and President of EastMed Inc. "Uresta (TM) Continence Care offers an innovative and cost-effective option for the many women who suffer from Stress Urinary Incontinence (SUI)."

Uresta(TM) Continence Care is designed to stop bladder leakage and empower women to manage their SUI with a conservative alternative to traditional products and surgery.

It is estimated that one in three women worldwide have incontinence and more than half of those women have SUI.

"SUI is a widespread, life altering condition and requires a solution that women can easily and comfortably manage," says Dr. Scott Farrell, Founder and VP Medical, EastMed. "Uresta(TM) Continence Care restores self-confidence and allows women to improve their quality of life."

Uresta(TM) Continence Care will be available by prescription in the United States.

EastMed Inc. is dedicated to inventing and bringing to market medical innovations for women's health and wellness. The company was recently awarded the 2008 Medical Design Excellence Award (MDEA) in recognition of its innovative design for women who suffer with SUI. EastMed has also received ISO world class quality certification, standards of quality recognized and respected throughout the world.


'/>"/>
SOURCE Eastmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor
2. Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
3. Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities
4. Cellectricon Receives Milestone Order for Cellaxess(R)HT, the Worlds First High Throughput RNAi Screening System
5. China Medical Technologies Receives SFDA Approval for Breast Cancer HER-2 FISH Probe
6. West Michigans Newest Medical Device Company Receives Support from the West Michigan Science & Technology Initiative and EDF Ventures
7. ProtoKinetix Receives Independent Confirmation of AAGP Anti-Inflammatory Action
8. Valor Medical Closes $1.4 Million Convertible Debt and Receives ISO 13485 Certification
9. Aposense Receives Frost & Sullivan Technology Innovation of the Year Award
10. Solos Endoscopy, Inc. Receives Purchase Order from Connecticut Hospital
11. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
Breaking Biology News(10 mins):